首页> 中文期刊> 《中国继续医学教育》 >磷酸肌酸钠与神经节苷脂早期治疗重度窒息新生儿的临床疗效分析

磷酸肌酸钠与神经节苷脂早期治疗重度窒息新生儿的临床疗效分析

         

摘要

Objective To investigate the clinical efficacy analysis phosphate sodium and ganglioside early treatment of severe neonatal asphyxia.MethodsSelected 60 cases of severe asphyxia newborns in ourhospital, which were randomly divided into two groups given conventional treatment, observation group were treated with phosphate sodium therapy of ganglioside. Analysis of clinical efficacy.ResultsCompared with the control group of children, clinical signs observed group of children shorter recovery time, low complication rate, and the difference was statistically significant (P<0.05).Conclusion The administration of severe neonatal asphyxia muscle sodium phosphate combined with ganglioside early treatment, can effectively reduce the incidence of complications, improve the cure rate of newborns with better clinical effcacy.%目的:探讨分析磷酸肌酸钠与神经节苷脂早期治疗重度窒息新生儿的临床疗效。方法选取我院重度窒息新生儿60例,随机分为两组,均给予常规治疗,观察组加用磷酸肌酸钠联合神经节苷脂治疗,分析两组临床疗效。结果与对照组患儿相比,观察组患儿临床体征恢复时间较短,并发症发生率较低,差异有统计学意义(P<0.05)。结论给予重度窒息新生儿磷酸肌酸钠联合神经节苷脂早期治疗,能有效减少并发症的发生,提高新生儿的治愈率,具有较好的临床疗效。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号